The therapeutic potential of calcipotriol in diseases other than psoriasis

Elisabeth A. Holm; Gregor B.E. Jemec

doi:10.1046/j.1365-4362.2002.01339.x

The therapeutic potential of calcipotriol in diseases other than psoriasis

Elisabeth A. Holm^*
, Gregor B.E. Jemec

^*Corresponding author for this work

Research output: Contribution to journal › Article › Research › peer-review

Abstract

Background: Calcipotriol is a vitamin D analog, which has antiproliferative and anti-inflammatory effects, and stimulates terminal differentiation. It has been an established treatment for psoriasis since 1991 in Europe and 1994 in the USA. Objective: To assess the clinical efficacy of topical calcipotriol in diseases other than psoriasis. Results: A total of 36 original papers were found describing 21 different diseases in which the clinical use of calcipotriol ointment was described as having an effect. These papers were predominantly case reports (n = 22) and observational studies (n = 5), but nine papers described small randomized controlled trials. Conclusions: Calcipotriol may generally be effective in diseases characterized by pathogenic elements, such as impaired differentiation or increased keratinocyte proliferation, and activated T lymphocytes. This study of the existing literature suggests that randomized, double-blind, placebo-controlled studies of calcipotriol therapy may be worthwhile in a number of diseases.

Original language	English
Pages (from-to)	38-43
Number of pages	6
Journal	International Journal of Dermatology
Volume	41
Issue number	1
DOIs	https://doi.org/10.1046/j.1365-4362.2002.01339.x
Publication status	Published - 14 Mar 2002

Access to Document

10.1046/j.1365-4362.2002.01339.x

Cite this

@article{e4f7eb722e9e4ffba64355d2b35e544b,

title = "The therapeutic potential of calcipotriol in diseases other than psoriasis",

abstract = "Background: Calcipotriol is a vitamin D analog, which has antiproliferative and anti-inflammatory effects, and stimulates terminal differentiation. It has been an established treatment for psoriasis since 1991 in Europe and 1994 in the USA. Objective: To assess the clinical efficacy of topical calcipotriol in diseases other than psoriasis. Results: A total of 36 original papers were found describing 21 different diseases in which the clinical use of calcipotriol ointment was described as having an effect. These papers were predominantly case reports (n = 22) and observational studies (n = 5), but nine papers described small randomized controlled trials. Conclusions: Calcipotriol may generally be effective in diseases characterized by pathogenic elements, such as impaired differentiation or increased keratinocyte proliferation, and activated T lymphocytes. This study of the existing literature suggests that randomized, double-blind, placebo-controlled studies of calcipotriol therapy may be worthwhile in a number of diseases.",

author = "Holm, \{Elisabeth A.\} and Jemec, \{Gregor B.E.\}",

year = "2002",

month = mar,

day = "14",

doi = "10.1046/j.1365-4362.2002.01339.x",

language = "English",

volume = "41",

pages = "38--43",

journal = "International Journal of Dermatology",

issn = "0011-9059",

publisher = "John Wiley \& Sons Inc.",

number = "1",

}

TY - JOUR

T1 - The therapeutic potential of calcipotriol in diseases other than psoriasis

AU - Holm, Elisabeth A.

AU - Jemec, Gregor B.E.

PY - 2002/3/14

Y1 - 2002/3/14

N2 - Background: Calcipotriol is a vitamin D analog, which has antiproliferative and anti-inflammatory effects, and stimulates terminal differentiation. It has been an established treatment for psoriasis since 1991 in Europe and 1994 in the USA. Objective: To assess the clinical efficacy of topical calcipotriol in diseases other than psoriasis. Results: A total of 36 original papers were found describing 21 different diseases in which the clinical use of calcipotriol ointment was described as having an effect. These papers were predominantly case reports (n = 22) and observational studies (n = 5), but nine papers described small randomized controlled trials. Conclusions: Calcipotriol may generally be effective in diseases characterized by pathogenic elements, such as impaired differentiation or increased keratinocyte proliferation, and activated T lymphocytes. This study of the existing literature suggests that randomized, double-blind, placebo-controlled studies of calcipotriol therapy may be worthwhile in a number of diseases.

AB - Background: Calcipotriol is a vitamin D analog, which has antiproliferative and anti-inflammatory effects, and stimulates terminal differentiation. It has been an established treatment for psoriasis since 1991 in Europe and 1994 in the USA. Objective: To assess the clinical efficacy of topical calcipotriol in diseases other than psoriasis. Results: A total of 36 original papers were found describing 21 different diseases in which the clinical use of calcipotriol ointment was described as having an effect. These papers were predominantly case reports (n = 22) and observational studies (n = 5), but nine papers described small randomized controlled trials. Conclusions: Calcipotriol may generally be effective in diseases characterized by pathogenic elements, such as impaired differentiation or increased keratinocyte proliferation, and activated T lymphocytes. This study of the existing literature suggests that randomized, double-blind, placebo-controlled studies of calcipotriol therapy may be worthwhile in a number of diseases.

UR - https://www.scopus.com/pages/publications/0036191756

U2 - 10.1046/j.1365-4362.2002.01339.x

DO - 10.1046/j.1365-4362.2002.01339.x

M3 - Article

C2 - 11895512

AN - SCOPUS:0036191756

SN - 0011-9059

VL - 41

SP - 38

EP - 43

JO - International Journal of Dermatology

JF - International Journal of Dermatology

IS - 1

ER -

The therapeutic potential of calcipotriol in diseases other than psoriasis

Abstract

Access to Document

Other files and links

Fingerprint

Cite this